✦ LIBER ✦

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

✍ Scribed by Mark Jit; Nadia Demarteau; Elamin Elbasha; Gary Ginsberg; Jane Kim; Naiyana Praditsitthikorn; Edina Sinanovic; Raymond Hutubessy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness and economic benefits

✍ Sachiko Ozawa; Andrew Mirelman; Meghan L. Stack; Damian G. Walker; Orin S. Levin 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 581 KB

Are Current Cost-Effectiveness Threshold

✍ Newall, A. T.; Jit, M.; Hutubessy, R. 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 278 KB

The vaccine uptake research gap in low-

✍ Noni E. MacDonald; Jennifer Smith; Michael Graven 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

Cost-Effectiveness of Haemophilus influe

✍ Griffiths, Ulla Kou; Clark, Andrew; Hajjeh, Rana 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 614 KB

Supporting the delivery of cost-effectiv

✍ Simon Lewin; John N Lavis; Andrew D Oxman; Gabriel Bastías; Mickey Chopra; Agust 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 157 KB

Cost effective interventions for the pre

✍ Amir Shroufi, Rajiv Chowdhury, Raghupathy Anchala, Sarah Stevens… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 296 KB